Company
United StatesPublic company, NYSE: STESteris PLC (NYSE: STE), Saint Louis, MO – FDA Inspections
Inspection records and compliance data for Steris PLC in Saint Louis, Missouri. 5 FDA inspections on record, 1 Form 483, last inspected November 06, 2023. Publicly traded as NYSE: STE.
Company Profile
This profile covers Steris PLC based in Saint Louis, Missouri, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 2
- NAI
- 3
- Form 483s
- 1
- Warning letters
- 0
First inspected July 16, 2009. Last inspected November 6, 2023.
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 6, 2023 | VAI | Human Drugs · Drug Quality Assurance | 1223087 |
| June 8, 2016 | NAI | Medical Devices & Rad Health · Compliance: Devices | 977303 |
| February 27, 2015 | NAI | Human Drugs, Medical Devices & Rad Health · Postmarket Assurance: Devices | 915094 |
| May 17, 2011 | NAI | Human Drugs, Medical Devices & Rad Health · Drug Quality Assurance | 724872 |
| July 16, 2009 | VAI | Human Drugs, Medical Devices & Rad Health · Compliance: Devices | 599535 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Steris PLC
Stock ticker
STE
Exchange
NYSE
Share price
$253.58
Market cap
$24.6B
Price as of
November 13, 2026
FEI Number
1937531
Address
7501 Page Ave, Saint Louis, Missouri 63133, United States
Country
United States
ID: 88ffc827-5fc2-41cd-b708-02b96911d97d